Indacaterol + Mometasone
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Indacaterol
indacaterol - Mometasone
mometasone
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| ATECTURA BREEZHALERAUCAESEUMX | 0.125 mg / 0.1275 mg / 0.26 mg / 0.0625 mg / 0.15 mg / 0.08 mg | Novartis Europharm Limited |
| indacaterol + mometasoneAUES | 0.125 mg / 0.1275 mg / 0.26 mg / 0.0625 mg | Novartis Europharm Limited |
| indacaterol + mometasonaES | 0.125 mg / 0.1275 mg / 0.26 mg / 0.0625 mg | Novartis Europharm Limited |
| ATECTURA BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /160 MCGHKSG | 0.15 mg / 0.16 mg / 0.32 mg / 0.08 mg | NOVARTIS (SINGAPORE) PTE LTD |
| BEMRIST BREEZHALERESEU | 0.125 mg / 0.1275 mg / 0.26 mg / 0.0625 mg | Novartis Europharm Limited |
| Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with deviceGB | — | Novartis Pharmaceuticals UK Ltd |
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with deviceGB | — | Novartis Pharmaceuticals UK Ltd |
| Atectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with deviceGB | — | Novartis Pharmaceuticals UK Ltd |
| Indacaterol 125micrograms/dose / Mometasone 127.5micrograms/dose inhalation powder capsules with deviceGB | — | Novartis Pharmaceuticals UK Ltd |
| Atectura Breezhaler 125micrograms/260micrograms inhalation powder capsules with deviceGB | — | Novartis Pharmaceuticals UK Ltd |
| Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with deviceGB | — | Novartis Pharmaceuticals UK Ltd |
| indacaterol acetate + mometasone furoateAU | — | — |
| ATECTURA BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhalerAU | 173 microgram / 320 microgram | Novartis Pharmaceuticals Australia Pty Ltd |
| ATECTURA BREEZHALER 125/127.5 indacaterol (as acetate)/mometasone furoate 125/127.5 mcg powder for inhalation in hard capsule with inhalerAU | 160 microgram / 173 microgram | Novartis Pharmaceuticals Australia Pty Ltd |
| ATECTURA BREEZHALER 125/62.5 indacaterol (as acetate)/mometasone furoate 125/62.5 microgram powder for inhalation in hard capsule with inhalerAU | 80 microgram / 173 microgram | Novartis Pharmaceuticals Australia Pty Ltd |
| BEMRIST BREEZHALER 125/62.5 indacaterol (as acetate)/mometasone furoate 125/62.5 microgram powder for inhalation in hard capsule with inhalerAU | 80 microgram / 173 microgram | Grand Medical Pty Ltd |
| BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhalerAU | 173 microgram / 320 microgram | Grand Medical Pty Ltd |
| BEMRIST BREEZHALER 125/127.5 indacaterol (as acetate)/mometasone furoate 125/127.5 mcg powder for inhalation in hard capsule with inhalerAU | 160 microgram / 173 microgram | Grand Medical Pty Ltd |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- CA · ATECTURA BREEZHALER · 3 products · record
- ES · ATECTURA BREEZHALER; BEMRIST BREEZHALER · 6 products · record
- GB · Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device; Atectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with device; Atectura Breezhaler 125micrograms/260micrograms inhalation powder capsules with device · 3 products · record
- MX · ATECTURA BREEZHALER · 1 products · record
- AU · ATECTURA BREEZHALER · 3 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.